10 20 30 40 50 60 70 80 1PL2 - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric Unit
HEADER TRANSFERASE 06-JUN-03 1PL2
TITLE CRYSTAL STRUCTURE OF HUMAN GLUTATHIONE TRANSFERASE (GST) A1- TITLE 2 1 T68E MUTANT IN COMPLEX WITH DECARBOXY-GLUTATHIONE
COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLUTATHIONE S-TRANSFERASE A1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: GTH1, HA SUBUNIT 1, GST-EPSILON, GSTA1-1, GST COMPND 5 CLASS-ALPHA; COMPND 6 EC: 2.5.1.18; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS DOMAIN1:ALPHA-BETA, DOMAIN2: ALPHA-HELICAL, TRANSFERASE
EXPDTA X-RAY DIFFRACTION
AUTHOR E.GRAHN,E.JAKOBSSON,A.GUSTAFSSON,L.GREHN,B.OLIN,M.WAHLBERG, AUTHOR 2 D.MADSEN,G.J.KLEYWEGT,B.MANNERVIK
REVDAT 4 24-FEB-09 1PL2 1 VERSN REVDAT 3 16-SEP-08 1PL2 1 JRNL REVDAT 2 14-FEB-06 1PL2 1 AUTHOR JRNL REVDAT 1 22-JUN-04 1PL2 0
JRNL AUTH E.GRAHN,M.NOVOTNY,E.JAKOBSSON,A.GUSTAFSSON,L.GREHN, JRNL AUTH 2 B.OLIN,D.MADSEN,M.WAHLBERG,B.MANNERVIK,G.J.KLEYWEGT JRNL TITL NEW CRYSTAL STRUCTURES OF HUMAN GLUTATHIONE JRNL TITL 2 TRANSFERASE A1-1 SHED LIGHT ON GLUTATHIONE BINDING JRNL TITL 3 AND THE CONFORMATION OF THE C-TERMINAL HELIX. JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 62 197 2006 JRNL REFN ISSN 0907-4449 JRNL PMID 16421451 JRNL DOI 10.1107/S0907444905039296
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.1.24 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 67.42 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 37339 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.165 REMARK 3 R VALUE (WORKING SET) : 0.161 REMARK 3 FREE R VALUE : 0.200 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 4148 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.85 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2567 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.1820 REMARK 3 BIN FREE R VALUE SET COUNT : 281 REMARK 3 BIN FREE R VALUE : 0.2180 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3625 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 54 REMARK 3 SOLVENT ATOMS : 528 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 16.02 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.40000 REMARK 3 B22 (A**2) : 0.93000 REMARK 3 B33 (A**2) : -0.45000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.69000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.137 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.126 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.077 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.407 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.959 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.939 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3750 ; 0.014 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 3559 ; 0.005 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5026 ; 1.461 ; 2.016 REMARK 3 BOND ANGLES OTHERS (DEGREES): 8344 ; 1.136 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 440 ; 5.515 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 541 ; 0.086 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4018 ; 0.009 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 736 ; 0.013 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 795 ; 0.218 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 4017 ; 0.242 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): 2087 ; 0.096 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 407 ; 0.144 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 9 ; 0.080 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 34 ; 0.237 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 27 ; 0.167 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2216 ; 0.828 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3581 ; 1.478 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1534 ; 2.209 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1445 ; 3.671 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS
REMARK 4 REMARK 4 1PL2 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-JUN-03. REMARK 100 THE RCSB ID CODE IS RCSB019403.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-FEB-01 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : MAX II REMARK 200 BEAMLINE : I711 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0793 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 41499 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.86 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.92 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.23 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 4000, TRIS-HCL, DTT, PH 7.8, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 49.61650 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 45.34750 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 49.61650 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 45.34750 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5240 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19830 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -48.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 899 LIES ON A SPECIAL POSITION. REMARK 375 HOH B 903 LIES ON A SPECIAL POSITION. REMARK 375 HOH B 904 LIES ON A SPECIAL POSITION.
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 MET B 1
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 146 CB - CG - OD2 ANGL. DEV. = 5.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 13 -76.89 -62.59 REMARK 500 GLN A 67 111.41 78.75 REMARK 500 ASP A 171 107.88 -169.24 REMARK 500 ARG B 13 -72.22 -60.50 REMARK 500 GLN B 67 111.49 76.07 REMARK 500 ASP B 171 105.99 -168.11 REMARK 500 REMARK 500 REMARK: NULL
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 601 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 602 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ABY A 654 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ABY B 655
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1PKW RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN GLUTATHIONE TRANSFERASE A1-1 IN REMARK 900 COMPLEX WITH GLUTATHIONE REMARK 900 RELATED ID: 1PKZ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN GLUTATHIONE TRANSFERASE A1-1 REMARK 900 COMPLEXED WITH 2-HYDROXYETHYL DISULFIDE REMARK 900 RELATED ID: 1PL1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN GLUTATHIONE TRANSFERASE A1-1 IN REMARK 900 COMPLEX WITH A DECARBOXY-GLUTATHIONE
DBREF 1PL2 A 1 222 UNP P08263 GSTA1_HUMAN 1 222 DBREF 1PL2 B 1 222 UNP P08263 GSTA1_HUMAN 1 222
SEQADV 1PL2 GLU A 68 UNP P08263 THR 67 ENGINEERED SEQADV 1PL2 CSO A 112 UNP P08263 CYS 111 MODIFIED RESIDUE SEQADV 1PL2 GLU B 68 UNP P08263 THR 67 ENGINEERED SEQADV 1PL2 CSO B 112 UNP P08263 CYS 111 MODIFIED RESIDUE
SEQRES 1 A 222 MET ALA GLU LYS PRO LYS LEU HIS TYR PHE ASN ALA ARG SEQRES 2 A 222 GLY ARG MET GLU SER THR ARG TRP LEU LEU ALA ALA ALA SEQRES 3 A 222 GLY VAL GLU PHE GLU GLU LYS PHE ILE LYS SER ALA GLU SEQRES 4 A 222 ASP LEU ASP LYS LEU ARG ASN ASP GLY TYR LEU MET PHE SEQRES 5 A 222 GLN GLN VAL PRO MET VAL GLU ILE ASP GLY MET LYS LEU SEQRES 6 A 222 VAL GLN GLU ARG ALA ILE LEU ASN TYR ILE ALA SER LYS SEQRES 7 A 222 TYR ASN LEU TYR GLY LYS ASP ILE LYS GLU ARG ALA LEU SEQRES 8 A 222 ILE ASP MET TYR ILE GLU GLY ILE ALA ASP LEU GLY GLU SEQRES 9 A 222 MET ILE LEU LEU LEU PRO VAL CSO PRO PRO GLU GLU LYS SEQRES 10 A 222 ASP ALA LYS LEU ALA LEU ILE LYS GLU LYS ILE LYS ASN SEQRES 11 A 222 ARG TYR PHE PRO ALA PHE GLU LYS VAL LEU LYS SER HIS SEQRES 12 A 222 GLY GLN ASP TYR LEU VAL GLY ASN LYS LEU SER ARG ALA SEQRES 13 A 222 ASP ILE HIS LEU VAL GLU LEU LEU TYR TYR VAL GLU GLU SEQRES 14 A 222 LEU ASP SER SER LEU ILE SER SER PHE PRO LEU LEU LYS SEQRES 15 A 222 ALA LEU LYS THR ARG ILE SER ASN LEU PRO THR VAL LYS SEQRES 16 A 222 LYS PHE LEU GLN PRO GLY SER PRO ARG LYS PRO PRO MET SEQRES 17 A 222 ASP GLU LYS SER LEU GLU GLU ALA ARG LYS ILE PHE ARG SEQRES 18 A 222 PHE SEQRES 1 B 222 MET ALA GLU LYS PRO LYS LEU HIS TYR PHE ASN ALA ARG SEQRES 2 B 222 GLY ARG MET GLU SER THR ARG TRP LEU LEU ALA ALA ALA SEQRES 3 B 222 GLY VAL GLU PHE GLU GLU LYS PHE ILE LYS SER ALA GLU SEQRES 4 B 222 ASP LEU ASP LYS LEU ARG ASN ASP GLY TYR LEU MET PHE SEQRES 5 B 222 GLN GLN VAL PRO MET VAL GLU ILE ASP GLY MET LYS LEU SEQRES 6 B 222 VAL GLN GLU ARG ALA ILE LEU ASN TYR ILE ALA SER LYS SEQRES 7 B 222 TYR ASN LEU TYR GLY LYS ASP ILE LYS GLU ARG ALA LEU SEQRES 8 B 222 ILE ASP MET TYR ILE GLU GLY ILE ALA ASP LEU GLY GLU SEQRES 9 B 222 MET ILE LEU LEU LEU PRO VAL CSO PRO PRO GLU GLU LYS SEQRES 10 B 222 ASP ALA LYS LEU ALA LEU ILE LYS GLU LYS ILE LYS ASN SEQRES 11 B 222 ARG TYR PHE PRO ALA PHE GLU LYS VAL LEU LYS SER HIS SEQRES 12 B 222 GLY GLN ASP TYR LEU VAL GLY ASN LYS LEU SER ARG ALA SEQRES 13 B 222 ASP ILE HIS LEU VAL GLU LEU LEU TYR TYR VAL GLU GLU SEQRES 14 B 222 LEU ASP SER SER LEU ILE SER SER PHE PRO LEU LEU LYS SEQRES 15 B 222 ALA LEU LYS THR ARG ILE SER ASN LEU PRO THR VAL LYS SEQRES 16 B 222 LYS PHE LEU GLN PRO GLY SER PRO ARG LYS PRO PRO MET SEQRES 17 B 222 ASP GLU LYS SER LEU GLU GLU ALA ARG LYS ILE PHE ARG SEQRES 18 B 222 PHE
MODRES 1PL2 CSO A 112 CYS S-HYDROXYCYSTEINE MODRES 1PL2 CSO B 112 CYS S-HYDROXYCYSTEINE
HET CSO A 112 7 HET CSO B 112 7 HET CL B 601 1 HET CL A 602 1 HET ABY A 654 26 HET ABY B 655 26
HETNAM CSO S-HYDROXYCYSTEINE HETNAM CL CHLORIDE ION HETNAM ABY N-(4-AMINOBUTANOYL)-S-(4-METHOXYBENZYL)-L- HETNAM 2 ABY CYSTEINYLGLYCINE
FORMUL 1 CSO 2(C3 H7 N O3 S) FORMUL 3 CL 2(CL 1-) FORMUL 5 ABY 2(C17 H25 N3 O5 S) FORMUL 7 HOH *527(H2 O)
HELIX 1 1 ARG A 13 ARG A 15 5 3 HELIX 2 2 MET A 16 ALA A 26 1 11 HELIX 3 3 SER A 37 ASP A 47 1 11 HELIX 4 4 GLN A 67 TYR A 79 1 13 HELIX 5 5 ASP A 85 LEU A 109 1 25 HELIX 6 6 PRO A 110 CSO A 112 5 3 HELIX 7 7 PRO A 113 ARG A 131 1 19 HELIX 8 8 ARG A 131 GLY A 144 1 14 HELIX 9 9 SER A 154 ASP A 171 1 18 HELIX 10 10 PHE A 178 LEU A 191 1 14 HELIX 11 11 LEU A 191 GLN A 199 1 9 HELIX 12 12 ASP A 209 ARG A 221 1 13 HELIX 13 13 ARG B 13 ARG B 15 5 3 HELIX 14 14 MET B 16 ALA B 26 1 11 HELIX 15 15 SER B 37 ASP B 47 1 11 HELIX 16 16 GLN B 67 TYR B 79 1 13 HELIX 17 17 ASP B 85 LEU B 109 1 25 HELIX 18 18 PRO B 110 CSO B 112 5 3 HELIX 19 19 PRO B 113 GLU B 115 5 3 HELIX 20 20 GLU B 116 ARG B 131 1 16 HELIX 21 21 ARG B 131 GLY B 144 1 14 HELIX 22 22 SER B 154 ASP B 171 1 18 HELIX 23 23 PHE B 178 LEU B 191 1 14 HELIX 24 24 LEU B 191 GLN B 199 1 9 HELIX 25 25 ASP B 209 ARG B 221 1 13
SHEET 1 A 4 GLU A 31 PHE A 34 0 SHEET 2 A 4 LYS A 6 TYR A 9 1 N LEU A 7 O LYS A 33 SHEET 3 A 4 MET A 57 ILE A 60 -1 O MET A 57 N HIS A 8 SHEET 4 A 4 MET A 63 VAL A 66 -1 O LEU A 65 N VAL A 58 SHEET 1 B 4 GLU B 31 PHE B 34 0 SHEET 2 B 4 LYS B 6 TYR B 9 1 N LEU B 7 O GLU B 31 SHEET 3 B 4 MET B 57 ILE B 60 -1 O MET B 57 N HIS B 8 SHEET 4 B 4 MET B 63 VAL B 66 -1 O LEU B 65 N VAL B 58
LINK C VAL A 111 N CSO A 112 1555 1555 1.33 LINK C CSO A 112 N PRO A 113 1555 1555 1.34 LINK C VAL B 111 N CSO B 112 1555 1555 1.34 LINK C CSO B 112 N PRO B 113 1555 1555 1.34
CISPEP 1 VAL A 55 PRO A 56 0 -0.23 CISPEP 2 VAL B 55 PRO B 56 0 0.94
SITE 1 AC1 4 PRO B 56 GLU B 68 ABY B 655 HOH B 676 SITE 1 AC2 3 PRO A 56 GLU A 68 ABY A 654 SITE 1 AC3 14 TYR A 9 ARG A 45 GLN A 54 VAL A 55 SITE 2 AC3 14 GLN A 67 LEU A 107 VAL A 111 MET A 208 SITE 3 AC3 14 PHE A 220 CL A 602 HOH A 806 HOH A 880 SITE 4 AC3 14 ASP B 101 ARG B 131 SITE 1 AC4 13 ASP A 101 ARG A 131 TYR B 9 ARG B 45 SITE 2 AC4 13 GLN B 54 VAL B 55 GLN B 67 LEU B 107 SITE 3 AC4 13 VAL B 111 MET B 208 PHE B 220 CL B 601 SITE 4 AC4 13 HOH B 828
CRYST1 99.233 90.695 51.158 90.00 93.39 90.00 C 1 2 1 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.010077 0.000000 0.000597 0.00000
SCALE2 0.000000 0.011026 0.000000 0.00000
SCALE3 0.000000 0.000000 0.019582 0.00000